Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2770 participants.
Also called NCT06095765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 2,770 participants
- Registry
-
NCT06095765
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Recruiting
Technical summary
Registry record NCT06095765. Randomized; single masking; primary purpose prevention. Start 2024-01-29 (actual); primary completion 2027-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
- Acronym
- COL BE PCI
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- AZ Sint-Jan AV
- Collaborator
- University Hospital, Ghent
- Collaborator
- Belgium Health Care Knowledge Centre
Record details
- Record id
cardio:ct-nct06095765- Content hash
a303092228f03c2a53dd5509e1f42b0f1858e8939c07f7fb997bf834bc80213e